Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Cbl-b, a target for drugs used to treat allergic asthma

Written by | 7 May 2014

Enzyme’s role is to ‘throw away’ protein if it overstays its welcome during immune response.  An enzyme that helps maintain immune system function by “throwing away” a specific… read more.

ACC 2014 Report: Underweight same high risk of dying as obese people

Written by | 29 Apr 2014

The connection between being underweight and the higher risk of dying is true for both adults and foetuses.  Being underweight puts people at highest risk of dying, just… read more.

Novel agent shows promise for non-small cell lung cancer

Written by | 3 Dec 2013

by Bruce Sylvester – Researchers report that an experimental cancer drug which has shown efficacy in  treating melanoma also shows promise  in treating non-small cell lung cancer, a… read more.

Survival in advanced pancreatic cancer significantly improved with nab-paclitaxel

Written by | 15 Nov 2013

by Bruce Sylvester – taken from the NEJM (New England Journal of Medicine) – Addition of nab-paclitaxel to gemcitabine for treatment of advanced pancreatic cancer has resulted in… read more.

ECC 2013: Late Breaking Clinical Trials: ASPECCT

Written by | 15 Nov 2013

by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.

Press Release – Halaven® data presented at ECCO 2013

Written by | 11 Oct 2013

17th ECCO – 38th ESMO – 32nd ESTRO – European Cancer Congress, Amsterdam RAI, 27 Sept – 1 Oct 2013. Eribulin represents a novel class of antineoplastic agents… read more.

ERS Report 2013 -1 in 10 of all deaths in Europe and cost EU countries at least 400 billion Euros annually; deaths due to lung cancer and COPD projected to increase

Written by | 11 Oct 2013

A major new publication from the European Respiratory Society (ERS) ahead of its annual congress, shows that lung conditions are responsible for 1 in 10 of all deaths… read more.

Green light for new medicines

Written by | 5 Sep 2013

EMA Highlights by Gary Finnegan – The EMA’s Committee for Medicinal Products for Human Use (CHMP) has a new member: Ivana Mikacic has been nominated by Croatia which… read more.

ASCO Interview 2013: Dr Brian Healey Bird gives us his feedback on the Lung Cancer Education Session at ASCO

Written by | 25 Jul 2013

Dr Brian Healey Bird FCPI.  Consultant Medical Oncologist, Bon Secours Cork.  Senior Clinical Lecturer, University College Cork.

ASCO 2013 – Cancer services in the United Kingdom: Improving nicely

Written by | 25 Jun 2013

by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.

ASCO 2013 Report – Advanced lung cancer with dysfunctional ALK gene responds to targeted therapy

Written by | 12 Jun 2013

by Bruce Sylvester – Patients with an advanced kind of lung cancer and a dysfunctional ALK gene have achieved better outcomes with the targeted investigative therapy crizotinib rather… read more.

ASCO 2013 Report – Lambrolizumab immunotherapy shows efficacy in advanced melanoma

Written by | 10 Jun 2013

Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.